Ginkgo Bioworks Stock Discussion

$Ginkgo Bioworks (DNA.US)$
NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture
Ginkgo Bioworks (NYSE: DNA) has announced a new partnership with NOVUS International to develop advanced feed additives for the animal agriculture industry. The collaboration aims to create more efficient enzymesthat can be produced cost-effectively using Ginkgo Enzyme Services. This initiative is designed to address the challenges faced by the agricultural sector, including ...

$Ginkgo Bioworks (DNA.US)$ 👀

$Ginkgo Bioworks (DNA.US)$
Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology
Ginkgo Bioworks (NYSE: DNA) has launched two new offerings to accelerate drug development, building on its partnership with Google Cloud. The first is a protein large language model (LLM)built with Google Cloud Consulting, designed to give researchers and companies insights from Ginkgo's private data. The second is a model API, allowing direct access to biological AI models.
Th...

$Ginkgo Bioworks (DNA.US)$ … Don’t buy.!!!!

$Ginkgo Bioworks (DNA.US)$ what were you doing on the $ROCHE HOLDING AG (RHHBY.US)$ and $Lumiradx acquisition completion press release.  
Lets go Bill!

$Ginkgo Bioworks (DNA.US)$
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) has regained compliance with the NYSE's minimum bid price requirement. The company received confirmation on September 3, 2024, that its Class A common stock had maintained a closing bid price at or above $1.00 for the required period. This follows a 1-for-40 reverse stock split implemented on August 20, 2024, to address the previous non-compliance notification received on May 7, 2024.
Simultaneously, Ginkgo received notice tha...